Bridgebio Pharma shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Bridgebio Pharma by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $11M | 143k | 74.26 |
| 2025-12-31 | $4.2M | 55k | 76.49 |
| 2025-09-30 | $42k | 814 | 51.94 |
| 2024-09-30 | $0 | 38 | 0.00 |
| 2024-06-30 | $98k | 3.9k | 25.10 |
| 2023-03-31 | $203k | 12k | 16.51 |
| 2022-12-31 | $576k | 76k | 7.62 |
| 2022-09-30 | $990k | 100k | 9.93 |
| 2022-06-30 | $230k | 25k | 9.05 |
| 2022-03-31 | $323k | 32k | 10.13 |
| 2021-12-31 | $317k | 19k | 16.68 |
| 2021-09-30 | $46k | 982 | 46.84 |
| 2020-12-31 | $478k | 6.7k | 71.07 |